Atnm Yahoo Finance (2024)

1. Actinium Pharmaceuticals, Inc. (ATNM)

Analysis
Find the latest Actinium Pharmaceuticals, Inc. (ATNM) stock quote, history, news and other vital information to help you with your stock trading and investing.

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage ...
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Find the latest ATNM Jul 2024 7.500 call (ATNM240719C00007500) stock quote ... Yahoo Finance · Sign in. Welcome to Yahoo! Select an account to sign in or ...
Find the latest ATNM Jul 2024 7.500 call (ATNM240719C00007500) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest Actinium Pharmaceuticals, Inc. (7AY1.F) stock quote, history, news and other vital information to help you with your stock trading and ...
See Also
Hannah Owo: Enthüllung einer Reise voller Inspiration und Erfolge 10 Free Chore Chart Templates to Get Things Done | ClickUp Filmizilla.com Hollywood Movies 25 of the Best Gender Reveal Ideas
Find the latest Actinium Pharmaceuticals, Inc. (7AY1.F) stock quote, history, news and other vital information to help you with your stock trading and investing.

Find the latest ATNM May 2024 12.500 call (ATNM240517C00012500) stock quote, history, news and other vital information to help you with your stock trading ...
Search for ticker symbols for Stocks, Mutual Funds, ETFs, Indices and Futures on Yahoo! Finance.

4 dagen geleden · Interactive Chart for ATNM Jul 2024 10.000 call (ATNM240719C00010000), analyze all the data with a huge range of indicators.
Interactive Chart for ATNM Jul 2024 10.000 call (ATNM240719C00010000), analyze all the data with a huge range of indicators.

At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage ...
See Also
Gender Reveal Ideas For Siblings - Make It Fun & Special!
At Yahoo Finance, you get free stock quotes, the latest news, portfolio management resources, international market data, social interaction and mortgage rates to help you manage your financial life.

ATNM Aug 2024 10.000 call · Is Actinium Pharmaceuticals (ATNM) Outperforming Other Medical Stocks This Year? · Treatment of Blood Cancers - Biopharma Companies ...
Find the latest ATNM240816C00010000 (ATNM240816C00010000) stock quote, history, news and other vital information to help you with your stock trading and investing.

20 jun 2024 · Actinium Pharmaceuticals (ATNM) is a stock that can certainly ... Yahoo Finance. Chipotle's 50-for-1 stock split just went into effect ...
Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.

20 jun 2024 · Here is how Actinium Pharmaceuticals (ATNM) and Encompass Health (EHC) have performed compared to their sector so far this year.
Get the latest Actinium Pharmaceuticals, Inc. (7AY1.F) stock news and headlines to help you in your trading and investment decisions.

Get the latest Actinium Pharmaceuticals Inc (ATNM) real-time quote ... Yahoo Finance. 20 hours ago. Starbucks (NASDAQ:SBUX) Looks To Prolong Its ...
Get the latest Actinium Pharmaceuticals Inc (ATNM) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ATNM scored across 33 valuation, financial, forecast, performance, and dividend ...
Actinium Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant or adoptive cell therapies. Its lead product candidate is Iomab-B, which is in a pivotal Phase III clinical trial as an induction and conditioning agent in patients over the age of 55 with relapsed or refractory acute myeloid leukemia prior to receiving a bone marrow transplant, also known as a hematopoietic stem cell transplant. The company is also developing Actimab-A, its lead alpha-particle drug candidate that is in a Phase II trial for patients newly diagnosed with AML age 60 and over; and Actimab-M, a drug candidate, for the treatment of patients with penta refractory multiple myeloma in a Phase 1 clinical trial. Its Antibody Warhead Enabling technology platform is currently being utilized in a research collaboration with Astellas Pharma, Inc. The company was founded in 2000 and is based in New York, New York.

Market Capitalization: 263.9 million. Links: ATNM on Yahoo Finance · Disclaimer | Privacy policy | FAQ | Digrin.com news | Affiliates (20% commission lifetime).
Price: $7.20